XBB subvariants not dominant in China: expert
BEIJING -- The COVID-19 Omicron XBB subvariants have not developed into dominant subvariants in China and will not cause a large-scale epidemic in the country at the current stage, according to an expert with the Chinese Center for Disease Control and Prevention (China CDC).
Chen Cao, research fellow with the National Institute for Viral Disease Control and Prevention under the China CDC, shared the information at a Sunday press conference held by the State Council joint prevention and control mechanism against COVID-19.
Noting the increasing risks of imported cases caused by XBB subvariants, Chen said the antibodies produced by individuals recently infected with BA.5.2 and BF.7 sub-strains will protect them from XBB subvariants to some extent.
In the meantime, the country has further strengthened the monitoring system on novel coronavirus variants and prepared targeted response plans, said Chen.
- Linqing: Where Grand Canal meets culinary crossroads
- Xi puts forward five-point proposal for building Asia-Pacific community
- Xi urges Asia-Pacific to jointly bolster universally beneficial, inclusive development
- Xi proposes Asia-Pacific jointly promote digitalization, greening of trade
- Xi says China not to close door to the outside world, will only open still wider
- Xi calls on APEC to jointly keep industrial, supply chains stable, smooth
